share_log

HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $6 Price Target

Benzinga ·  Apr 3, 2023 10:14

HC Wainwright & Co. analyst Vernon Bernardino reiterates Citius Pharma (NASDAQ:CTXR) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment